Skip to megamenu (after main content)
Meet us next:   BIO International Convention 2025 – 4 September  ●  ELRIG – Drug Discovery in Scotland 2025 – 17 September  ●  The Cell & Gene Meeting on the Mesa 2025 – 6-8 October (in person) & 9-10 October (virtual)  ●  ELRIG – Drug Discovery – 21-22 October  ●  more on our events calendar
Prices for NutriStem, NutriCoat, and NutriFreez products will increase effective 1st August. Lock in the current price by getting your order by 31st July.

    Recombinant human IL-8 protein

    QK119

    Brand: Qkine

    Interleukin-8 (IL-8) is an inflammatory cytokine that acts as a chemoattractant to neutrophils. It promotes the differentiation of hematopoietic progenitors into monocytic lineages including megakaryocytes, monocytes and macrophages. IL-8 can be used for the culture and differentiation of reproducible and high-quality hematopoietic stem cells and proliferation and migration in relevant cells.

    Qkine recombinant human IL-8 has a molecular weight of 8.9 kDa. This protein is animal origin-free, carrier-free and tag-free to ensure its purity with exceptional lot-to-lot consistency.

    Currency: 

    Product name Catalog number Pack size Price Price (USD) Price (GBP) Price (EUR)
    Recombinant human IL-8 protein, 25 µg QK119-0025 25 µg (select above) $ 210.00 £ 115.00 € 175.00
    Recombinant human IL-8 protein, 50 µg QK119-0050 50 µg (select above) $ 315.00 £ 225.00 € 263.00
    Recombinant human IL-8 protein, 100 µg QK119-0100 100 µg (select above) $ 500.00 £ 375.00 € 438.00
    Recombinant human IL-8 protein, 500 µg QK119-0500 500 µg (select above) $ 1,995.00 £ 1,475.00 € 1,723.00
    Recombinant human IL-8 protein, 1000 µg QK119-1000 1000 µg (select above) $ 3,100.00 £ 2,300.00 € 2,687.00

    Note: prices shown do not include shipping and handling charges.

    Qkine company name and logo are the property of Qkine Ltd. UK.

    Alternative protein names
    Interleukin-8, C-X-C motif chemokine 8, Chemokine (C-X-C motif) ligand 8, Emoctakin, Granulocyte chemotactic protein 1 (GCP-1), Monocyte-derived neutrophil chemotactic factor (MDNCF), Monocyte-derived neutrophil-activating peptide (MONAP), Neutrophil-activating protein 1 (NAP-1), Protein 3-10C, T-cell chemotactic factor, IL 8, IL8
    Species reactivity
    • human
    • species similarity:
    • mouse - 80%
    • bovine - 76%
    • porcine -76%

    Summary

    • High purity human protein (Uniprot: P10145)
    • 8.9 kDa (monomer)
    • >98%, by SDS-PAGE quantitative densitometry
    • Expressed in E. coli
    • Animal origin-free (AOF) and carrier protein-free
    • Manufactured in Qkine's Cambridge, UK laboratories
    • Lyophilized from acetonitrile, TFA
    • Resuspend in 10 mM HCl (Reconstitution solution A) at >50 µg/ml, add carrier protein if desired, prepare single-use aliquots and store frozen at -20 °C (short-term) or -80 °C (long-term)
    Handling and Storage FAQ

    Featured applications

    • Differentiation into monocytic lineages
    • Chemotaxis experiments
    • Differentiation of osteoclasts

    Bioactivity

    Recombinant IL-8 activity was determined using an IL-8-responsive firefly luciferase reporter assay. Transfected HEK293T cells were treated in triplicate with a serial dilution of IL-8 for 3 hours. Firefly activity was measured and normalized to the control Renilla luciferase activity. Data from Qk119 lot #204742. EC50 = 49 ng/ml (5.44 nM).

    Qk119-Datasheet-graph_-Website

    Purity

    Recombinant IL-8 migrates as a major band at approximately 11 kDa in reduced (R) and non-reduced (NR) conditions. No contaminating protein bands are present. The purified recombinant protein 3 µg was resolved using 15% w/v SDS-PAGE in reduced (+β-mercaptoethanol, R) and non-reduced (NR) conditions and stained with Coomassie Brilliant Blue R250. Data from Qk119 lot #204742.

    IL-8-gel-1024x1024

    Further quality assays

    • Mass spectrometry: single species with expected mass
    • Recovery from stock vial:  >95%
    • Endotoxin: <0.005 EU/μg protein (below level of detection)

    Protein background

    Interleukin-8 (IL-8 or CXCL8) is a C-X-C motif family chemokine. IL-8 was originally identified through its chemotactic activity on neutrophil and named monocyte-derived neutrophil chemotactic factor (MDNCF) [1]. IL-8 is translated as 99 amino acid precursor before processing to the 72 amino acid biologically active form. In humans IL-8 has 2 receptors, CXCR1 and CXCR2, both G-protein coupled receptors [1, 4]. Binding of IL-8 to its receptors activates downstream pathways including Akt/PKB, MAPK, and PKC, regulating cell adhesion and migration.

    IL-8 is an inflammatory cytokine produced by several cell types including fibroblasts, lung epithelial cells, endothelial cells, keratinocytes, T cells, neutrophils, mast cells, monocytes and macrophages [2, 4]. As well as its role in inflammation IL-8 has been shown to play a role in tumor growth and vascularization. In triple negative breast cancer, IL-8 expression is closely related to prognosis and is being investigated as a potential therapeutic target [3].

    IL-8 also acts as a growth factor for human hematopoietic progenitors, promoting the growth and differentiation of cells of monocytic lineages including megakaryocytes, monocytes and macrophages [4]. Recombinant IL-8 has been shown to stimulate differentiation of human peripheral blood mononuclear cells into osteoclasts [5].

    Background references

    1. Matsushima K, Yang D and Oppenheim JJ, Interleukin-8: An evolving chemokine, Cytokine (2022). doi.org/10.1016/j.cyto.2022.155828.
    2. Benakanakere M, Finoti L, Tanaka U et al. Investigation of the functional role of human Interleukin-8 gene haplotypes by CRISPR/Cas9 mediated genome editing. Sci Rep 6 (2016). doi.org/10.1038/srep31180
    3. Deng F, Weng Y, Li X et al. Overexpression of IL-8 promotes cell migration via PI3K-Akt signaling pathway and EMT in triple-negative breast cancer, Pathology - Research and Practice (2020). doi.org/10.1016/j.prp.2020.152902.
    4. Corre I, Pineau D and Hermouet S. Interleukin-8: an autocrine/paracrine growth factor for human hematopoietic progenitors acting in synergy with colony stimulating factor-1 to promote monocyte-macrophage growth and differentiation. Exp Hematol. (1999). doi: 10.1016/s0301-472x(98)00032-0.
    5. Bendre MS, Montague DC, Peery T et al. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone (2003). doi.org/10.1016/S8756-3282(03)00086-3.

    FAQ

    What is IL-8?
    IL-8 is a proinflammatory cytokine which attracts neutrophils to the site of inflammation.

    Where is IL-8 found?
    IL-8 is a soluble protein found in serum. IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis, and metastasis.

    Is IL-8 a cytokine?
    Yes IL-8 is a cytokine

    What does the IL-8 gene do?
    IL-8 is encoded by the CXCL8, IL-8 gene expression is induced by a wide variety of agents including cytokines, growth factors, bacterial and viral products and oxidants.

    What does IL-8 bind to?
    IL-8 has two receptors CXCR1 and CXCR2

    What is the function of the IL-8 receptor?
    Both IL-8 receptors are G protein coupled and cause an increase in cGMP and activate Akt/PKB, MAPK, and PKC, regulating cell adhesion and migration.

    What is the IL-8 pathway?
    IL-8 binding to CXCR1 and CXCR2 activates various downstream molecules, including G proteins, small GTPases (Ras, Rac, Rho), and kinases (PI3K, PLC, PKC, AKT). This activates cell adhesion, actin polymerization, membrane protrusion, and eventually cell migration.

    How is IL-8 used in cell culture?
    IL-8 can be used to differentiate pluripotent cells into monocytic lineages or osteoclasts. IL-8 can also be used in chemotaxis studies.